Clinical Trial Update: The Effect of Q10 and Selen Supplement on Muscular Adverse Events in Statin Therapy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated whether Coenzyme Q10 and selenium supplementation influence muscular adverse events in patients taking statins; the study has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Hyperlipidemia

Drugs mentioned

• Coenzyme Q10 (Coenzyme Q10)
• Selenium (selenium)

Snippet

Sponsor: Oslo University Hospital | Conditions: Statin Therapy | Phase 4 | Status: COMPLETED